• Carbapenemase Genes in CREC: Transmission and Resistance in

  2026-07-25

  This study provides a comprehensive molecular and epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) isolated from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The findings reveal a high prevalence of plasmid-borne blaNDM−1, multidrug resistance, and efficient horizontal gene transfer, highlighting urgent challenges for antibiotic resistance surveillance and informing laboratory approaches.

• YAP-NF-κB Axis Regulates Pyroptosis in Ulcerative Colitis Mo

  2026-07-24

  This study elucidates how inactivation of YAP by NF-κB p65 promotes colonic epithelial cell pyroptosis in ulcerative colitis, via regulation of NLRP3. The findings highlight a mechanistic link between inflammation-induced signaling and pyroptotic cell death, offering direction for targeted UC therapies.

• Reactive Oxygen Species Assay Kit: Precision with DHE Probe

  2026-07-24

  Unlock sensitive, reproducible detection of intracellular superoxide with the APExBIO Reactive Oxygen Species (ROS) Assay Kit (DHE). This guide demystifies optimized workflows, troubleshooting, and translational research applications—empowering your oxidative stress and apoptosis studies.

• Leptin (116-130), amide, mouse: Protocols for Metabolic Rese

  2026-07-23

  Leptin (116-130), amide, mouse, offers a powerful tool for dissecting the metabolic and immunomodulatory pathways behind obesity, diabetes, and related cardiovascular-immune dysfunctions. This guide details advanced workflows, troubleshooting, and translational opportunities, helping researchers leverage this adipocyte-derived hormone fragment for robust, reproducible discoveries.

• Ceftolozane Sulfate: Mechanistic Precision and Next-Gen PK/P

  2026-07-23

  Explore the advanced mechanisms and translational PK/PD frontiers of Ceftolozane sulfate, a cephalosporin with potent bactericidal activity against Pseudomonas aeruginosa. This cornerstone article unpacks new comparative data and practical considerations for cutting-edge infectious disease research.

• Dabigatran in Anticoagulation Research: Mechanistic Precisio

  2026-07-22

  Explore how Dabigatran (Pradaxa) redefines thrombin inhibition in advanced anticoagulation research. This article analyzes mechanistic nuances, protocol guidance, and translational insights not covered in standard guides.

• Practical Use of 740 Y-P: Protocols for PI 3-Kinase Activati

  2026-07-22

  740 Y-P is a cell-permeable PI 3-kinase activator that enables researchers to modulate the PI3K/AKT signaling pathway, supporting studies in vesicular trafficking, apoptosis, and neuronal survival. It is best suited for well-controlled biochemical or cell-based assays where reliable and reversible PI3K activation is required. Use outside validated cell or biochemical contexts is not advised due to limited cross-domain evidence.

• Sodium Phosphate Dibasic: Optimizing Biological Assay Buffer

  2026-07-21

  Sodium phosphate dibasic (Na2HPO4) is a gold-standard pH stabilizer that ensures reliable assay performance in aquatic toxicity and molecular biology workflows. This article delivers actionable protocol enhancements, troubleshooting insights, and practical translation of aquatic toxicology research—empowering researchers to maximize buffer reproducibility and experimental rigor.

• 4-Hydroxytamoxifen: Technical Guidance for Research Applicat

  2026-07-21

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator essential for DMSO-based research applications in breast and prostate cancer, apoptosis, and cardiac myocyte studies. It is unsuitable for workflows requiring aqueous or ethanol solubility, and strict storage and preparation protocols are critical for maintaining reagent integrity.

• Ferritin-Based Hybrid Vaccine: Dual Antigen Display for Infl

  2026-07-20

  The referenced study introduces a ferritin-based hybrid protein particle vaccine that simultaneously displays influenza A M2e and SARS-CoV-2 S-protein tandem epitopes. This approach, leveraging E. coli expression, achieves enhanced and broadened immune responses in mice, suggesting a promising platform for future combination vaccines targeting multiple viral pathogens.

• ATRX Deficiency Increases Glioma Sensitivity to RTK/PDGFR In

  2026-07-20

  This study identifies that high-grade glioma cells lacking ATRX function display heightened sensitivity to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. The findings provide a mechanistic rationale for integrating ATRX mutation status into therapeutic strategies and trial designs for aggressive gliomas.

• α-Bungarotoxin: Precision Nicotinic Receptor Blockade in Res

  2026-07-19

  Unlock the full potential of α-Bungarotoxin for high-specificity nicotinic receptor blockade in advanced neuroscience and placental necroptosis models. This article delivers actionable protocols, troubleshooting insights, and cross-domain applications that set APExBIO’s reagent apart for targeted research.

• Mianserin HCl: Mechanistic Insights and Cross-Domain Researc

  2026-07-18

  Explore the unique mechanistic profile and multidimensional research applications of Mianserin HCl, a 5-HT2 receptor antagonist. This in-depth analysis uncovers novel assay considerations and bridges antidepressant and antipathogenic research, providing critical insight for advanced psychiatric disorder and metabolic studies.

• Nano-Granulated Zoledronate Reprograms Innate Immunity via M

  2026-07-17

  Chen et al. report a nano-granulated zoledronate (Nano-ZD) formulation that redirects metabolic modulation specifically to lymph node-resident innate immune cells, enhancing both vaccine-induced and antitumor responses. Their work identifies the mevalonate–CoQ–OXPHOS/pyrimidine axis as a promising target for immunometabolic adjuvant design, advancing the precision of nanotechnology-enabled immune modulation.

• Mitoxantrone in Anticancer Research: Protocols, Resistance,

  2026-07-17

  Mitoxantrone offers dual utility as a potent apoptosis inducer in B-CLL cells and an effective antitumor agent in multidrug-resistant cancer models. This article delivers stepwise experimental workflows, new resistance-reversal strategies, and advanced troubleshooting guidance for oncology researchers leveraging APExBIO’s high-purity compound.

449 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page